SlideShare una empresa de Scribd logo
1 de 20
Chronic Kidney Diseases and Its
Causes, Trends and Corrective
Actions Needed to Take in the
Developing World
Presented by-
Dr. Jheelam Biswas
Dept of NCD
BUHS
Outlines
 Introduction
 Background
 Causes of CKD
 Global trends of CKD over years
 CKD: Bangladesh context
 Corrective actions to be taken
 Conclusion
Introduction
• Chronic kidney disease (CKD) is now recognized
as a public health priority worldwide, with a high
economical cost to health system of developing
countries.
• It is an independent risk factor for
cardiovascular diseases, therefore premature
deaths and decreased quality of life.
Background
• Chronic kidney diseases can be defined by the
indicators of renal insufficiency like proteinuria,
changes in kidney structure detected by imaging
or increased serum creatinine.
• Worldwide, estimated 200 million people suffer
from CKD, and the estimated prevalence of
stages 1 to 5 was 13.4% among which 10.6% are
in stages 3 to 5. (1)
• Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age
groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;
380: 2095–2128
Background (cont..)
• Globally, more than 100 countries have no
provisions for chronic maintenance dialysis or
kidney transplantation and thus, more than 1
million people die annually from ESRD.
• The health expenditure of CKD in USA was 6.3%
and in Bangladesh the was 3.7% of gross
domestic product (GDP). (2)
• (2) Roy S. Determinants of healthcare expenditure on human capital and economic growth in Bangladesh: a
longitudinal data analysis from 1995–2010. Asian J Pharm Res Health Care 2014; 6: 6–10
Background (cont..)
• It affects all age groups, but in young and
middle aged population, development of CKD
causes loss of income, and increased social and
economic burden.
• It is a big concern for developing countries
because of the increasing prevalence, high
health expenditure, and low socioeconomic
condition.
Causes of CKD
CGN, 25.50%
Diabeties, 41%
Hypertension,
33%
others, 0.90%
Source: Bangladesh Renal journal 2004
Global trend of CKD over years:
• Like all other NCD, CKD is now becoming one of
the global health challenges.
• 2002–03, the third Australian Diabetes, Obesity
and Lifestyle (AusDiab) study showed a high
prevalence of CKD in the USA and Australia, 16
and 14%, respectively.
Global trend (cont…)
• In the same year European countries and China
the prevalence rate was around 10%.
• But after 2003, in USA, incidence rates of ESRD
have been stable, and five years later the
annual incidence rate almost fell to zero for the
first time. (3)
• Weinhandl E, Constantini E, Everson S, Gilbertson D, Li S, Solid C, et al. Peer kidney care initiative 2014 report:
dialysis care and outcomes in the United States. Am J Kidney Dis. 2015;65 Suppl 1:S1–140.
Global trend (cont…)
• But in the developing countries the picture was
exactly opposite.
• In 2015, India had a prevalence rate of 6.3%, in
stage 3 of CKD.
• In Srilanka the CKD prevalence was 34.3%, and in
Pakistan (according to Pakistan renal registry
2013) 7260 patients are on dialysis currently.
CKD: Bangladesh Context
• No reliable prior data exists on prevalence of
CKD in Bangladesh.
• In 1994, a small scale study reveals that, 24% of
the patients presented with diabetic
nephropathy, in 1998, 31% (an increase of 7%)
and in 2013, 41% (a further increase of 10%
compared with 1998). (4)
• (4) Abraham G. The challenges of renal replacement therapy in Asia. Nat Clin Pract Nephrol 2008;
4: 643
CKD: Bangladesh Context
• According to NKF, CKD prevalence of 16- 18% in
Bangladesh; of them, 11% belong to stage-III
and above in 2014.
• According to renal registry 2010, prevalence of
ESRD in Bangladesh was 30-35 thousand per
year. In 2013, 7007 patients could access renal
replacement therapy.
CKD: Bangladesh Context
• Almost 80% RRT centers in Bangladesh are profit
based.
• Cost of single dialysis ranges from 3500-5000
taka per dialysis (US$ 44-62.00) .
• In 2013, more than 80% patients could not
access RRT, and therefore died.
Prevalence of Hemodialysis from 1998 to 2014 (NKF yearbook 2016)
Corrective actions to be taken
• To control the increasing burden of CKD in the
developing countries and decrease the disparity
between rich and poor in access to RRT both
governmental and international partnership is
needed.
• But as always, prevention is better than cure.
Corrective actions (cont…)
• Primary prevention:
 Screening and raising awareness
 Prevention of LBW
 Early detection and control of diabetes and
hypertension
 Stopping the use of OTC and herbal drugs
 Lifestyle modification.
Corrective actions (cont…)
• Secondary prevention:
 Early detection and treatment
 Achieving good glycemic control and control of
hypertension with appropriate drugs in the
patients with early stage of CKD.
 Reducing disparity in access to RRT
Corrective actions (cont…)
• National and Local health planning:
 Improving medical materials, methods and
processes used in screening, treatment and
monitoring of CKD
 Financial management
 Training of local health providers
 Building international partnership
Conclusion:
• The increased burden of CKD in developing
countries is due to globalization, low
socioeconomic status, and poor access to health
care and health care disparities.
• By early detection, treatment increasing
community outreach, and access to preventive
medicine for high risk population, can decrease
the rising burden of CKD.

Más contenido relacionado

La actualidad más candente

Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. GawadChronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. GawadNephroTube - Dr.Gawad
 
Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019FarragBahbah
 
Kidney health for everyone everywhere final
Kidney health for everyone everywhere finalKidney health for everyone everywhere final
Kidney health for everyone everywhere finalNilesh Jadhav
 
Management of chronic kidney disease
Management of chronic kidney diseaseManagement of chronic kidney disease
Management of chronic kidney diseaseShivshankar Badole
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadNephroTube - Dr.Gawad
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisIPMS- KMU KPK PAKISTAN
 
Heart failure with CKD : How to Treat ?
Heart failure with CKD : How to Treat ?Heart failure with CKD : How to Treat ?
Heart failure with CKD : How to Treat ?drucsamal
 
Awareness and Prevention for Kidney diseases
Awareness and Prevention for Kidney diseases Awareness and Prevention for Kidney diseases
Awareness and Prevention for Kidney diseases ExpressClinicsIndia
 
Renovascular disorders
Renovascular disordersRenovascular disorders
Renovascular disorderssahar Hamdy
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysisReynel Dan
 
Diabetes + Kidney disease
Diabetes + Kidney diseaseDiabetes + Kidney disease
Diabetes + Kidney diseaseRichard McCrory
 
Role of erythropoitin in chronic kidney disease
Role of erythropoitin in chronic kidney diseaseRole of erythropoitin in chronic kidney disease
Role of erythropoitin in chronic kidney diseaseAftab Siddiqui
 
Ckd mbd guideline
Ckd mbd guidelineCkd mbd guideline
Ckd mbd guidelinedrsam123
 
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....NephroTube - Dr.Gawad
 
Chronic renal failure(2010505)
Chronic renal failure(2010505)Chronic renal failure(2010505)
Chronic renal failure(2010505)internalmed
 
Presentation: HCV in dialysis
Presentation: HCV in dialysisPresentation: HCV in dialysis
Presentation: HCV in dialysisdrsalwa22000
 

La actualidad más candente (20)

Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
 
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. GawadChronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
Chronic Kidney Disease (CKD) - At a Glance - Dr. Gawad
 
Chronic Kidney Disease
Chronic Kidney DiseaseChronic Kidney Disease
Chronic Kidney Disease
 
Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019Ramadan fasting & kidney disease may 2019
Ramadan fasting & kidney disease may 2019
 
Kidney health for everyone everywhere final
Kidney health for everyone everywhere finalKidney health for everyone everywhere final
Kidney health for everyone everywhere final
 
Management of chronic kidney disease
Management of chronic kidney diseaseManagement of chronic kidney disease
Management of chronic kidney disease
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
 
Heart failure with CKD : How to Treat ?
Heart failure with CKD : How to Treat ?Heart failure with CKD : How to Treat ?
Heart failure with CKD : How to Treat ?
 
Awareness and Prevention for Kidney diseases
Awareness and Prevention for Kidney diseases Awareness and Prevention for Kidney diseases
Awareness and Prevention for Kidney diseases
 
Renovascular disorders
Renovascular disordersRenovascular disorders
Renovascular disorders
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Diabetes + Kidney disease
Diabetes + Kidney diseaseDiabetes + Kidney disease
Diabetes + Kidney disease
 
Role of erythropoitin in chronic kidney disease
Role of erythropoitin in chronic kidney diseaseRole of erythropoitin in chronic kidney disease
Role of erythropoitin in chronic kidney disease
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Ckd mbd guideline
Ckd mbd guidelineCkd mbd guideline
Ckd mbd guideline
 
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
Hemodialysis Anticoagulation - Different Protocols / Protocol Selection - Dr....
 
Chronic renal failure(2010505)
Chronic renal failure(2010505)Chronic renal failure(2010505)
Chronic renal failure(2010505)
 
Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019Chronic Kidney Disease Update 2019
Chronic Kidney Disease Update 2019
 
Presentation: HCV in dialysis
Presentation: HCV in dialysisPresentation: HCV in dialysis
Presentation: HCV in dialysis
 

Similar a Chronic kidney diseases and its causes and trends in global and Bangladesh perspective

Global burden of CKD
Global burden of CKDGlobal burden of CKD
Global burden of CKDRahul Ranjan
 
Changing epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicChanging epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicGoral Gondnale Vora
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Clifford Thornton
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’drsanjaymaitra
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptxPoojakarki10
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health RegulationSujata Mohapatra
 
Burden of nc ds, policies and programme for
Burden of nc ds, policies and programme forBurden of nc ds, policies and programme for
Burden of nc ds, policies and programme forDr. Dharmendra Gahwai
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart diseasedrsanjeev15
 
Esrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestEsrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestFAARRAG
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePratikshya kisiju
 
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014Feisul Mustapha
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxjeanettehully
 
NHS Atlas of Variation in Healthcare for People with Liver Disease
NHS Atlas of Variation in Healthcare for People with Liver DiseaseNHS Atlas of Variation in Healthcare for People with Liver Disease
NHS Atlas of Variation in Healthcare for People with Liver Diseaserightcare
 
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocationIncreasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocationFeisul Mustapha
 
Ncd non communicable diseases presentation
Ncd non communicable diseases presentationNcd non communicable diseases presentation
Ncd non communicable diseases presentationMohan Bastola
 
Diabetes atlas key headlines 2012
Diabetes atlas   key headlines 2012Diabetes atlas   key headlines 2012
Diabetes atlas key headlines 2012rightcare
 

Similar a Chronic kidney diseases and its causes and trends in global and Bangladesh perspective (20)

Global burden of CKD
Global burden of CKDGlobal burden of CKD
Global burden of CKD
 
Changing epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmicChanging epidemiology of cardiovascular diseases in lmic
Changing epidemiology of cardiovascular diseases in lmic
 
jacksonn_Old1
jacksonn_Old1jacksonn_Old1
jacksonn_Old1
 
International Journal of Nephrology & Therapeutics
International Journal of Nephrology & TherapeuticsInternational Journal of Nephrology & Therapeutics
International Journal of Nephrology & Therapeutics
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
 
Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’Concept of a ‘CKD Clinic’
Concept of a ‘CKD Clinic’
 
NCD presentation.pptx
NCD presentation.pptxNCD presentation.pptx
NCD presentation.pptx
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health Regulation
 
Burden of nc ds, policies and programme for
Burden of nc ds, policies and programme forBurden of nc ds, policies and programme for
Burden of nc ds, policies and programme for
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
Esrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestEsrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latest
 
Presentation on Ischemic Heart Disease
Presentation on Ischemic Heart DiseasePresentation on Ischemic Heart Disease
Presentation on Ischemic Heart Disease
 
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014
Public heath challenges for NCDs, UHC and cost effective treatment, MySPOR 2014
 
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docxRunning head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
Running head MEDICAL CARE PLANNING FOR PATIENTS WITH CHRONIC KIDN.docx
 
NHS Atlas of Variation in Healthcare for People with Liver Disease
NHS Atlas of Variation in Healthcare for People with Liver DiseaseNHS Atlas of Variation in Healthcare for People with Liver Disease
NHS Atlas of Variation in Healthcare for People with Liver Disease
 
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocationIncreasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
 
Ncd non communicable diseases presentation
Ncd non communicable diseases presentationNcd non communicable diseases presentation
Ncd non communicable diseases presentation
 
Ckd 2016 100 1
Ckd 2016 100 1Ckd 2016 100 1
Ckd 2016 100 1
 
Prevention of Diabetes visual impairment and blindness
Prevention of  Diabetes visual impairment and blindness Prevention of  Diabetes visual impairment and blindness
Prevention of Diabetes visual impairment and blindness
 
Diabetes atlas key headlines 2012
Diabetes atlas   key headlines 2012Diabetes atlas   key headlines 2012
Diabetes atlas key headlines 2012
 

Más de BSMMU

47-yr-old lady with monoplegia: A case
47-yr-old lady with monoplegia: A case 47-yr-old lady with monoplegia: A case
47-yr-old lady with monoplegia: A case BSMMU
 
Cerebellum and basal ganglia
Cerebellum and basal gangliaCerebellum and basal ganglia
Cerebellum and basal gangliaBSMMU
 
Lupus nephritis with pregnancy
Lupus nephritis with pregnancyLupus nephritis with pregnancy
Lupus nephritis with pregnancyBSMMU
 
Updated management of Wilson's disease
Updated management of Wilson's diseaseUpdated management of Wilson's disease
Updated management of Wilson's diseaseBSMMU
 
Case presentation: Hypoplastic right heart
Case presentation: Hypoplastic right heart Case presentation: Hypoplastic right heart
Case presentation: Hypoplastic right heart BSMMU
 
Proteinuria how to approach
Proteinuria how to approach Proteinuria how to approach
Proteinuria how to approach BSMMU
 
Case presentation: spindle cell tumour
Case presentation: spindle cell tumourCase presentation: spindle cell tumour
Case presentation: spindle cell tumourBSMMU
 
Case presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancerCase presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancerBSMMU
 
Obesity and NCD
Obesity and NCDObesity and NCD
Obesity and NCDBSMMU
 
MDG Bangladesh Update
MDG Bangladesh UpdateMDG Bangladesh Update
MDG Bangladesh UpdateBSMMU
 
Management of burn in pediatric patients
Management of burn in pediatric patientsManagement of burn in pediatric patients
Management of burn in pediatric patientsBSMMU
 
Genetics of childhood solid tumors
Genetics of childhood solid tumorsGenetics of childhood solid tumors
Genetics of childhood solid tumorsBSMMU
 
Case report: Empty sella syndrome
Case report: Empty sella syndromeCase report: Empty sella syndrome
Case report: Empty sella syndromeBSMMU
 
Demographic transition and its relation to NCD
Demographic transition and its relation to NCDDemographic transition and its relation to NCD
Demographic transition and its relation to NCDBSMMU
 
CSF and it’s abnormalities
CSF and it’s abnormalitiesCSF and it’s abnormalities
CSF and it’s abnormalitiesBSMMU
 
Opioids dependence and management
Opioids dependence and managementOpioids dependence and management
Opioids dependence and managementBSMMU
 
Case presentation: Chronic pancreatitis
Case presentation: Chronic pancreatitisCase presentation: Chronic pancreatitis
Case presentation: Chronic pancreatitisBSMMU
 
Cardiac rehabilitation
Cardiac rehabilitation Cardiac rehabilitation
Cardiac rehabilitation BSMMU
 

Más de BSMMU (18)

47-yr-old lady with monoplegia: A case
47-yr-old lady with monoplegia: A case 47-yr-old lady with monoplegia: A case
47-yr-old lady with monoplegia: A case
 
Cerebellum and basal ganglia
Cerebellum and basal gangliaCerebellum and basal ganglia
Cerebellum and basal ganglia
 
Lupus nephritis with pregnancy
Lupus nephritis with pregnancyLupus nephritis with pregnancy
Lupus nephritis with pregnancy
 
Updated management of Wilson's disease
Updated management of Wilson's diseaseUpdated management of Wilson's disease
Updated management of Wilson's disease
 
Case presentation: Hypoplastic right heart
Case presentation: Hypoplastic right heart Case presentation: Hypoplastic right heart
Case presentation: Hypoplastic right heart
 
Proteinuria how to approach
Proteinuria how to approach Proteinuria how to approach
Proteinuria how to approach
 
Case presentation: spindle cell tumour
Case presentation: spindle cell tumourCase presentation: spindle cell tumour
Case presentation: spindle cell tumour
 
Case presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancerCase presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancer
 
Obesity and NCD
Obesity and NCDObesity and NCD
Obesity and NCD
 
MDG Bangladesh Update
MDG Bangladesh UpdateMDG Bangladesh Update
MDG Bangladesh Update
 
Management of burn in pediatric patients
Management of burn in pediatric patientsManagement of burn in pediatric patients
Management of burn in pediatric patients
 
Genetics of childhood solid tumors
Genetics of childhood solid tumorsGenetics of childhood solid tumors
Genetics of childhood solid tumors
 
Case report: Empty sella syndrome
Case report: Empty sella syndromeCase report: Empty sella syndrome
Case report: Empty sella syndrome
 
Demographic transition and its relation to NCD
Demographic transition and its relation to NCDDemographic transition and its relation to NCD
Demographic transition and its relation to NCD
 
CSF and it’s abnormalities
CSF and it’s abnormalitiesCSF and it’s abnormalities
CSF and it’s abnormalities
 
Opioids dependence and management
Opioids dependence and managementOpioids dependence and management
Opioids dependence and management
 
Case presentation: Chronic pancreatitis
Case presentation: Chronic pancreatitisCase presentation: Chronic pancreatitis
Case presentation: Chronic pancreatitis
 
Cardiac rehabilitation
Cardiac rehabilitation Cardiac rehabilitation
Cardiac rehabilitation
 

Último

Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Último (20)

Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Chronic kidney diseases and its causes and trends in global and Bangladesh perspective

  • 1. Chronic Kidney Diseases and Its Causes, Trends and Corrective Actions Needed to Take in the Developing World Presented by- Dr. Jheelam Biswas Dept of NCD BUHS
  • 2. Outlines  Introduction  Background  Causes of CKD  Global trends of CKD over years  CKD: Bangladesh context  Corrective actions to be taken  Conclusion
  • 3. Introduction • Chronic kidney disease (CKD) is now recognized as a public health priority worldwide, with a high economical cost to health system of developing countries. • It is an independent risk factor for cardiovascular diseases, therefore premature deaths and decreased quality of life.
  • 4. Background • Chronic kidney diseases can be defined by the indicators of renal insufficiency like proteinuria, changes in kidney structure detected by imaging or increased serum creatinine. • Worldwide, estimated 200 million people suffer from CKD, and the estimated prevalence of stages 1 to 5 was 13.4% among which 10.6% are in stages 3 to 5. (1) • Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095–2128
  • 5. Background (cont..) • Globally, more than 100 countries have no provisions for chronic maintenance dialysis or kidney transplantation and thus, more than 1 million people die annually from ESRD. • The health expenditure of CKD in USA was 6.3% and in Bangladesh the was 3.7% of gross domestic product (GDP). (2) • (2) Roy S. Determinants of healthcare expenditure on human capital and economic growth in Bangladesh: a longitudinal data analysis from 1995–2010. Asian J Pharm Res Health Care 2014; 6: 6–10
  • 6. Background (cont..) • It affects all age groups, but in young and middle aged population, development of CKD causes loss of income, and increased social and economic burden. • It is a big concern for developing countries because of the increasing prevalence, high health expenditure, and low socioeconomic condition.
  • 7. Causes of CKD CGN, 25.50% Diabeties, 41% Hypertension, 33% others, 0.90% Source: Bangladesh Renal journal 2004
  • 8. Global trend of CKD over years: • Like all other NCD, CKD is now becoming one of the global health challenges. • 2002–03, the third Australian Diabetes, Obesity and Lifestyle (AusDiab) study showed a high prevalence of CKD in the USA and Australia, 16 and 14%, respectively.
  • 9. Global trend (cont…) • In the same year European countries and China the prevalence rate was around 10%. • But after 2003, in USA, incidence rates of ESRD have been stable, and five years later the annual incidence rate almost fell to zero for the first time. (3) • Weinhandl E, Constantini E, Everson S, Gilbertson D, Li S, Solid C, et al. Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States. Am J Kidney Dis. 2015;65 Suppl 1:S1–140.
  • 10. Global trend (cont…) • But in the developing countries the picture was exactly opposite. • In 2015, India had a prevalence rate of 6.3%, in stage 3 of CKD. • In Srilanka the CKD prevalence was 34.3%, and in Pakistan (according to Pakistan renal registry 2013) 7260 patients are on dialysis currently.
  • 11.
  • 12. CKD: Bangladesh Context • No reliable prior data exists on prevalence of CKD in Bangladesh. • In 1994, a small scale study reveals that, 24% of the patients presented with diabetic nephropathy, in 1998, 31% (an increase of 7%) and in 2013, 41% (a further increase of 10% compared with 1998). (4) • (4) Abraham G. The challenges of renal replacement therapy in Asia. Nat Clin Pract Nephrol 2008; 4: 643
  • 13. CKD: Bangladesh Context • According to NKF, CKD prevalence of 16- 18% in Bangladesh; of them, 11% belong to stage-III and above in 2014. • According to renal registry 2010, prevalence of ESRD in Bangladesh was 30-35 thousand per year. In 2013, 7007 patients could access renal replacement therapy.
  • 14. CKD: Bangladesh Context • Almost 80% RRT centers in Bangladesh are profit based. • Cost of single dialysis ranges from 3500-5000 taka per dialysis (US$ 44-62.00) . • In 2013, more than 80% patients could not access RRT, and therefore died.
  • 15. Prevalence of Hemodialysis from 1998 to 2014 (NKF yearbook 2016)
  • 16. Corrective actions to be taken • To control the increasing burden of CKD in the developing countries and decrease the disparity between rich and poor in access to RRT both governmental and international partnership is needed. • But as always, prevention is better than cure.
  • 17. Corrective actions (cont…) • Primary prevention:  Screening and raising awareness  Prevention of LBW  Early detection and control of diabetes and hypertension  Stopping the use of OTC and herbal drugs  Lifestyle modification.
  • 18. Corrective actions (cont…) • Secondary prevention:  Early detection and treatment  Achieving good glycemic control and control of hypertension with appropriate drugs in the patients with early stage of CKD.  Reducing disparity in access to RRT
  • 19. Corrective actions (cont…) • National and Local health planning:  Improving medical materials, methods and processes used in screening, treatment and monitoring of CKD  Financial management  Training of local health providers  Building international partnership
  • 20. Conclusion: • The increased burden of CKD in developing countries is due to globalization, low socioeconomic status, and poor access to health care and health care disparities. • By early detection, treatment increasing community outreach, and access to preventive medicine for high risk population, can decrease the rising burden of CKD.